heart-treatment-device

FDA thumbs up to Abbott's MitraClip device

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration (FDA) has supported Abbott's MitraClip device stating that the benefits of the treatment device outweigh its risks.... Read more

tb-fight-needs-money

Fight against TB needs $1.6 bn funding annually

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight... Read more

novartis-eye-care-firm-gets-eu-nod-for-jetrea

Novartis eye care firm gets EU nod for Jetrea

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval for Jetrea intravitreal injection (ocriplasmin)... Read more

orexo-sells-abstral-to-galena-biopharma-in-us

Orexo sells Abstral to Galena Biopharma in US

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Swedish company Orexo has sold Abstral (fentanyl) sublingual tablets in the US to Galena Biopharma. Under the terms of the agreement, Galena Biopharma... Read more

marketing-application

Vanda Pharma withdraws application for Fanaptum

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketing authorization for the medicine Fanaptum... Read more

sgs-expands-services-towards-biologics-testing

SGS expands services towards biologics testing

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Contract analytical and bioanalytical service provider, SGS Life Science Services, is investing on integrated formulation and stability testing services... Read more

agreement-bgi-gennet

BGI Europe, GENNET sign deal for Mendelian disorders

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BGI Europe, one of BGI's affiliates, and GENNET, a center for genetics, fetal medicine and assisted reproduction, signed a memorandum of understanding... Read more

globaldata-estimates-the-osteoporosis-therapeutics-market-to-reach-usd8-billion-in-2022-from-usd6-billion-in-2012

GlobalData: Osteoporosis market to be $8 bn

  • US
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a... Read more

takeda-seeks-eu-marketing-authorization-for-vedolizumab

Takeda seeks bowel drug marketing nod from EU

  • Japan
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Takeda Pharmaceutical submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for vedolizumab, an investigational,... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X